December 2013

Rheonix Inc. Raises $14 Million to Scale Manufacturing for 2014 Product Launch

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, raised $14 million in a combination of debt and equity investments to complete a manufacturing build out and launch its first commercial product. The funds will be used to expand the company’s physical operations to produce consumables and systems to fulfill Rheonix’s joint development agreement with Life Technologies Corp. and for the commercialization of its first clinical,… Read More »

Rheonix to Use $14M Financing to Support Life Tech Food Testing Pact, Build Own MDx Test Menu

With $14 MILLION in debt and equity financing in hand, molecular diagnostics firm Rheonix is planning to expand both its physical footprint and molecular testing product portfolio in the coming year, company president Tony Eisenhut said this week. First, Rheonix is already in the process of building out new manufacturing facilities just down the street from its current Ithaca, NY, headquarters, primarily to enable it to produce consumables and systems to… Read More »

Rheonix Executive to Address Effects of Automated Molecular Diagnostic Solutions on Laboratory Workflow

ITHACA, N.Y. — Genetic testing laboratories currently face constraints such as complex sample preparation, complicated workflow and long waits for test results. Molecular diagnostics executive Richard Montagna, Ph.D., vice president for scientific affairs for Rheonix Inc., an Ithaca-based developer of an automated molecular testing platform, will present ways to overcome some of these challenges and provide cost-effective molecular diagnostics for personalized medicine at an international conference later this month. “We are… Read More »